Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Scientific Reports
|
May 11, 2018
Inhibition of Bcl-2/Bcl-xL and c-MET causes synthetic lethality in model systems of glioblastoma
Yiru Zhang, Chiaki Tsuge Ishida, Chang Shu, et al.
Biomaterials Advances
|
September 15, 2023
Co-delivery of azithromycin and ibuprofen by ROS-responsive polymer nanoparticles synergistically attenuates the acute lung injury
Wali Muhammad, Yiru Zhang, Jiaqi Zhu, et al.
Nature Communications
|
October 24, 2017
Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL
Georg Karpel-Massler, Chiaki Tsuge Ishida, Elena Bianchetti, et al.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi
|
July 8, 2016
[A Maternal Health Care System Based on Mobile Health Care]
Xin Du, Weijie Zeng, Chengwei Li, et al.
BMC Plant Biology
|
January 4, 2026
Genotype × environment interactions underlying geographic divergence in carotenoid accumulation and kernel pigmentation of foxtail millet
Xin Zhao, Yueyue Wang, Ziyi Deng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 27, 2025
Chronic stress-induced cholesterol metabolism abnormalities promote ESCC tumorigenesis and predict neoadjuvant therapy response
Ting Wang, Xiangyu Wang, Keke Wang, et al.
EMBO Molecular Medicine
|
August 31, 2019
Activation of LXRβ inhibits tumor respiration and is synthetically lethal with Bcl-xL inhibition
Trang Thi Thu Nguyen, Chiaki Tsuge Ishida, Enyuan Shang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2018
Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma
Yiru Zhang, Chiaki Tsuge Ishida, Wataru Ishida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2018
Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma
Chiaki T Ishida, Yiru Zhang, Elena Bianchetti, et al.
Genes & Diseases
|
February 12, 2026
Multiomic insights into the MPO-mediated NET formation pathway in alcohol-induced epilepsy risk
Ningning Zhang, Sirui Chen, Jialing Jiang, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Scientific Reports
|
May 11, 2018
Inhibition of Bcl-2/Bcl-xL and c-MET causes synthetic lethality in model systems of glioblastoma
Yiru Zhang, Chiaki Tsuge Ishida, Chang Shu, et al.
Biomaterials Advances
|
September 15, 2023
Co-delivery of azithromycin and ibuprofen by ROS-responsive polymer nanoparticles synergistically attenuates the acute lung injury
Wali Muhammad, Yiru Zhang, Jiaqi Zhu, et al.
Nature Communications
|
October 24, 2017
Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL
Georg Karpel-Massler, Chiaki Tsuge Ishida, Elena Bianchetti, et al.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi
|
July 8, 2016
[A Maternal Health Care System Based on Mobile Health Care]
Xin Du, Weijie Zeng, Chengwei Li, et al.
BMC Plant Biology
|
January 4, 2026
Genotype × environment interactions underlying geographic divergence in carotenoid accumulation and kernel pigmentation of foxtail millet
Xin Zhao, Yueyue Wang, Ziyi Deng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 27, 2025
Chronic stress-induced cholesterol metabolism abnormalities promote ESCC tumorigenesis and predict neoadjuvant therapy response
Ting Wang, Xiangyu Wang, Keke Wang, et al.
EMBO Molecular Medicine
|
August 31, 2019
Activation of LXRβ inhibits tumor respiration and is synthetically lethal with Bcl-xL inhibition
Trang Thi Thu Nguyen, Chiaki Tsuge Ishida, Enyuan Shang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2018
Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma
Yiru Zhang, Chiaki Tsuge Ishida, Wataru Ishida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2018
Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma
Chiaki T Ishida, Yiru Zhang, Elena Bianchetti, et al.
Genes & Diseases
|
February 12, 2026
Multiomic insights into the MPO-mediated NET formation pathway in alcohol-induced epilepsy risk
Ningning Zhang, Sirui Chen, Jialing Jiang, et al.
Page
of 8